Literature DB >> 11389060

Human cutaneous fatty acid-binding protein induces metastasis by up-regulating the expression of vascular endothelial growth factor gene in rat Rama 37 model cells.

C Jing1, C Beesley, C S Foster, H Chen, P S Rudland, D C West, H Fujii, P H Smith, Y Ke.   

Abstract

Human cutaneous fatty acid-binding protein (C-FABP) gene is capable of inducing the metastatic phenotype when overexpressed in nonmetastatic rat Rama 37 cells. However, the mechanism of how it induces metastasis is not clear. Northern and slot blot analyses revealed that expression of the endogenous vascular endothelial growth factor (VEGF) gene was increased by 3.8-5.2-fold in the C-FABP-transfected cells (pSV-CFABP-R37) and in their metastatic sublines (e.g., Met-1) when compared with that in the nonmetastatic control transfectant pSV-R37 cells generated by transfection of only plasmid DNA. Higher levels of VEGF immunoreactive protein were also secreted from the malignant C-FABP-expressing cells. Reverse transcription-PCR detected two VEGF transcript isoforms, VEGF(164) and VEGF(188), in both the nonmetastatic control transfectant pSV-R37 cells and the malignant metastatic Met-1 cells. Chick chorioallantoic membrane assays showed that the conditioned medium of the control pSV-R37 cells possessed only very weak angiogenic activity, whereas conditioned media from the metastatic C-FABP transfectants and their sublines were strongly angiogenic and could be inhibited by antibodies to VEGF. Transfection of VEGF(164) cDNA in an expression vector into nonmetastatic Rama 37 cells produced a cell clone (R37-VEGF-2) that expressed high levels of VEGF. Inoculation of R37-VEGF-2 cells into syngeneic Wistar Furth rats produced metastases in a significant number (Fisher's exact test, P < 0.01) of animals (18 of 31 animals), whereas the control, vector alone-transfected R37-PSV cells produced no metastases (0 of 30 animals). Immunocytochemical methods demonstrated a strong positive staining for VEGF and an increased microvessel density in the primary tumors produced from PSV-VEGF-2 cells in comparison with tumors produced from control transfectants. Immunocytochemical staining for factor VIII detected a 3.5-fold increase in microvessel density of the primary tumors produced by PSV-VEGF-2 cells when compared with that of the primary tumors developed from the control pSV-R37 cells. Therefore, we suggest that overexpression of the C-FABP gene in the original transfectants induces metastasis through up-regulation of expression of the VEGF gene in this rat Rama 37 model system, and thus VEGF may play a crucial role in this particular metastatic cascade.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11389060

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  32 in total

1.  Chromosome 6 abnormalities correlated with thymoma progression.

Authors:  Hidefumi Sasaki; Yoshitaka Fujii; Nobuyuki Ide
Journal:  Am J Pathol       Date:  2003-12       Impact factor: 4.307

2.  Effects of kampo formulas on the progression of hypercholesterolemia and Fatty liver induced by high-cholesterol diet in rats.

Authors:  Weibin Qian; Junichi Hasegawa; Satoshi Tsuno; Yusuke Endo; Akiko Matsuda; Norimasa Miura
Journal:  Yonago Acta Med       Date:  2014-12-26       Impact factor: 1.641

3.  Genomic profiling of hormone-naïve lymph node metastases in patients with prostate cancer.

Authors:  Pamela L Paris; Matthias D Hofer; Giancarlo Albo; Rainer Kuefer; Juergen E Gschwend; Richard E Hautmann; Jane Fridyland; Jeffrey Simko; Peter R Carroll; Mark A Rubin; Colin Collins
Journal:  Neoplasia       Date:  2006-12       Impact factor: 5.715

4.  Tissue microarray of head and neck squamous carcinoma: validation of the methodology for the study of cutaneous fatty acid-binding protein, vascular endothelial growth factor, involucrin and Ki-67.

Authors:  Wafaey Gomaa; Youqiang Ke; Hiroshi Fujii; Timothy Helliwell
Journal:  Virchows Arch       Date:  2005-10-19       Impact factor: 4.064

5.  Fatty acid-binding protein 5 and PPARbeta/delta are critical mediators of epidermal growth factor receptor-induced carcinoma cell growth.

Authors:  Padmamalini Kannan-Thulasiraman; Darcie D Seachrist; Ganapati H Mahabeleshwar; Mukesh K Jain; Noa Noy
Journal:  J Biol Chem       Date:  2010-04-27       Impact factor: 5.157

6.  Association of FABP5 expression with poor survival in triple-negative breast cancer: implication for retinoic acid therapy.

Authors:  Rong-Zong Liu; Kathryn Graham; Darryl D Glubrecht; Devon R Germain; John R Mackey; Roseline Godbout
Journal:  Am J Pathol       Date:  2011-03       Impact factor: 4.307

7.  FABP5 correlates with poor prognosis and promotes tumor cell growth and metastasis in cervical cancer.

Authors:  Wei Wang; Hong-Juan Chu; Yan-Chun Liang; Jia-Ming Huang; Chun-Liang Shang; Hao Tan; Duo Liu; Yun-He Zhao; Tian-Yu Liu; Shu-Zhong Yao
Journal:  Tumour Biol       Date:  2016-09-19

8.  All-trans retinoic acid inhibits craniopharyngioma cell growth: study on an explant cell model.

Authors:  Qiang Li; Chao You; Liangxue Zhou; Xiutian Sima; Zhiyong Liu; Hao Liu; Jianguo Xu
Journal:  J Neurooncol       Date:  2013-02-20       Impact factor: 4.130

9.  Involvement of Fatty Acid Binding Protein 5 and PPARβ/δ in Prostate Cancer Cell Growth.

Authors:  Elwin Morgan; Padmamalini Kannan-Thulasiraman; Noa Noy
Journal:  PPAR Res       Date:  2010-08-19       Impact factor: 4.964

Review 10.  Fatty acid-binding proteins: role in metabolic diseases and potential as drug targets.

Authors:  Masato Furuhashi; Gökhan S Hotamisligil
Journal:  Nat Rev Drug Discov       Date:  2008-06       Impact factor: 84.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.